in the current issue of the NEJM, we have another example of the drug
industry's ability to convince physicians to prescribe their new products,
even if they cause more harm than good to the patients, as compared with the
older, and less expensive remedies
http://content.nejm.org/cgi/reprint/354/11/1193.pdf
is the situation worse or better in the field of diagnostics?
joseph watine, rodez, france
------ACB discussion List Information--------
This is an open discussion list for the academic and clinical
community working in clinical biochemistry.
Please note, archived messages are public and can be viewed
via the internet. Views expressed are those of the individual and
they are responsible for all message content.
ACB Web Site
http://www.acb.org.uk
List Archives
http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html
List Instructions (How to leave etc.)
http://www.jiscmail.ac.uk/
|